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Previous evidence has shown that the MI and L pyruvate kinase isozymes differ markedly in kinetic and 
immunological properties, amino acid compositions and peptide maps. However, the amino acid sequence 
results we present here for the N-terminal region and for a region of the C domain show that the Mr and 
L isozymes are very similar. The variable length of the N-terminal sequences also explains the difference 
in regulation by phosphorylation between the Mr and L isozymes. The MI isozyme lacks the serine residue 
that has been shown to be phosphorylated in the L isozyme. 
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1. INTRODUCTION 
Pyruvate kinase (PK, EC 2.7. I .40) is active in all 
cells during glycolysis, and catalyses the formation 
of ATP by the transfer of a phospho group from 
phosphoenolpyruvate to ADP. There is a require- 
ment for divalent and monovalent cations (usually 
Mg2+ and K+). Four different isozymes of PK exist 
in vertebrate tissues: Ml isozyme in skeletal mus- 
cle, Mz isozyme in kidneys, L isozyme in liver, and 
R isozyme in erythrocytes. All are tetramers with 
identical subunits of appro~mate M; 60000. These 
isozymes differ in their kinetic properties, with the 
Mi enzyme showing hyperbolic Michaelis-Menten 
kinetics, and the L enzyme being allosterically 
regulated (review [l]). The activity of the L 
isozyme is decreased by phosphorylation whereas 
the Ml enzyme is not phosphorylated [2,3]. 
The control of expression of the 4 PK isozymes 
is particularly interesting. There is one gene that 
codes for the L and R isozymes, but there are two 
different mRNAs [4]. Similarly, it is likely that 
there is one gene for Mi PK and Mz PK [5], but 
two different mRNAs [6]. Thus, the L and R 
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isozymes are closely related to each other as are the 
Mi and Mt isozymes. 
Evidence has shown that the Ml and L isozymes 
differ markedly in kinetic and immunologist pro- 
perties, amino acid compositions and peptide maps 
[1,7]. However, we report here amino acid se- 
quence information that shows that the Mi and L 
isozymes are very similar. 
2. MATERIALS AND METHODS 
2.1. F~ri~c~tio~ of MI and L pyruvate kineses 
Pyruvate kinase was purified from cat and from 
rat skeletal muscle by a procedure based on that 
devised in [8]. The method involves ammonium 
sulphate precipitation, affinity elution from 
CM-cellulose by phosphoenolpyruvate, and gel 
filtration. The L isozyme was purified from rat 
liver according to a modification of the method in 
191. In the modified procedure the final 
chromatography steps on DEAE-cellulose and 
CM-cellulose were replaced by selective absorp- 
tion of L PK to Sepharose procion blue MX-R in 
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the presence of Mg2+, and elution by removal of 
the divalent cation (in preparation). 
2.2. Isolation of peptides 
Reduced and carboxymethylated cat Mi and rat 
L isozymes were treated with CNBr (lOO-fold 
molar excess over methionine residues for 24 h at 
room temperature), and the resulting peptides were 
separated on Cig and phenyl reverse-phase col- 
umns by HPLC. Peptides CN24, CN40, CN34a, 
CBl, CN34, CN9, CNl and CB2 were purified in 
this way. Peptide CN24SP2 was purified by HPLC 
from a staphylococcal protease digest of CN24 
(that had a blocked N-terminus). The cat M1 
isozyme was also digested with clostripain [lo]. 
The protein was reduced, carboxymethylated and 
citraconylated prior to digestion, and the protease 
was pretreated with 10 mM DTE for 2 h at 4°C. 
Digestion was done at pH 7.5 for 2 h at 37°C at a 
protein/protease ratio of 125 : 1 and at 1.5 mg pro- 
tein/ml of 20 mM ammonium bicarbonate. The 
peptides were isolated by prefractionation on 
Sephadex followed by Aminex A5 or SP-Sephadex 
cation exchangers, as well as by HPLC on Cig or 
phenyl reverse-phase columns. 
2.3. Sequence determination 
Automated liquid-phase sequencing of the 
CNBr peptides and CL13 was done with a 
Beckman 890C sequencer fitted with the Beckman 
cold-trap accessory. The details of the sequencer 
operation and the identification of the 
phenylthiohydantoin derivatives have been 
described [ 111. Automated solid-phase sequencing 
of the clostripain peptides was done as in [12], ex- 
cept that the amino acid phenylthiohydantoins 
were identified by HPLC. 
3. RESULTS AND DISCUSSION 
The amino acid sequences of two regions of L 
and Mi PK are compared in fig. 1. The N-terminus 
of rat Mi PK is unblocked (although cat Ml PK is 
blocked), and this allowed the N-terminal sequence 
of 35 residues to be established irectly. The cat Ml 
PK sequence was obtained from sequence analysis 
of clostripain and CNBr peptides as shown in the 
figure. The initial and repetitive yields of represen- 
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tative peptides are given in table 1. The two Mi PK 
sequences are identical except for the N-terminal 7 
residues where there are 4 amino acid replacements 
(89% sequence identity over the 35 residues 
compared). 
The Ml and L PK sequences are clearly closely 
related, with 66 of the 104 (or 63%) of the residues 
compared being identical. It is apparent, however, 
that the N-terminal portions of the two isozymes 
are quite different. The sequence determined in 
[ 131 corresponded to a CNBr peptide derived from 
rat L PK, and it is therefore possible that there 
may be additional residues N-terminal to the pep- 
tide. If a comparison is made of residues 8-63 then 
77% of the residues are identical; 56% of the 
residues from 407-447 are identical. 
The high resolution crystallographic structure of 
cat Ml PK [14] shows that each subunit consists of 
3 distinct domains. The active site is located bet- 
ween domains A and B at the carboxy end of the 
eight-stranded P-barrel that forms the core of the 
largest domain, A. The N-terminal, approximately 
10 residues appear to form a relatively flexible 
portion of the subunit before the polypeptide chain 
continues into a more ordered region and then into 
the first P-strand of domain A. A comparison of 
the sequences of cat Ml PK, chicken muscle PK 
and yeast PK shows that domain A is more highly 
conserved than either domain B or C, and that 
there are substantial variations at the N-terminus 
(the yeast enzyme is 22 residues shorter at the N- 
terminus) [15]. The sequence results reported here 
show that L and Mr PK also have similar structural 
relationships: (i) the two isozymes differ in length 
at the N-terminus; (ii) residues 1 l-64 from domain 
A show less variation than residues 407-447 from 
domain C. 
The variable N-terminal sequences also provide 
a simple structural basis to explain the difference 
in regulation by phosphorylation between Mi and 
L PK. This explanation has already been suggested 
from a comparison of the sequence of chicken 
muscle PK deduced from mRNA [16] with the se- 
quence of phosphoserine-containing peptides from 
rat and pig L PK reported in [ 131. Our results com- 
paring the N-terminal sequences of the Mi and L 
isozymes from the same mammalian species con- 
firm this explanation. It is apparent by homology 
that the C-terminal portion of the phosphopeptide 
from L PK corresponds to the N-terminal part of 
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Mt PK. The muscle enzyme is shorter at the N- characteristic site for specific phosphorylation and 
terminus by at least 12 residues, and thus lacks the dephosphorylation in L PK and similarly 
serine flanked by positive charges that is the modulated enzymes. 
t-- Cl.28 * 
k-CN24SPl _1 I- CN24SP2 -+ CN40 __) 
Cat H, PK 
Rat M, PK 
RatL PK . 
I CB 033 ----d+--CBl- 
~-j~---_ CL23 -{_ CL14 _c_I :- CL27 - 
I CN34a + 
Cat Ml PK 
Rat Ml PK 
RatL PK 
M CBl I 
4 CL13 II- CL7 -_-1ccL2+CL24l 
l-CN34-lCCN3-l 1 CNl * 
t CB2 * 
Fig.1. Comparison of amino acid sequences from Ml and L pyruvate kinases. Peptides designated CN were derived 
from CNBr cleavage of cat Mr PK, CL from clostripain digestion of cat Mt PK and CB from CNBr cleavage of rat 
L PK. The solid lines indicate that the sequence has been determined; the dashed lines show any unsequenced regions. 
The residues are numbered according to the cat MI PK sequence. Identical residues are boxed in. The serine that can 
be phosphorylated in L PK is shown by an asterisk. 
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Table 1 
Initial and repetitive yields of sequenced peptides 
Initial yield 
nmol 070 
Repetitive yield 
(070) 
Rat Mr PK 8 ND 95 
CN24SP2 9 45 91 
CN40 23 45 93 
CN34a 12 52 95 
CBl 8 40 97 
CL13 10 36 90 
CNl 3 35 92 
CB2 6 30 95 
The repetitive yields were calculated by linear regression 
analysis; recoveries of PTH-Ser, PTH-Thr, PTH-Be, 
PTH-CMCys and PTH-Trp were not included in the 
analysis. ND, not determined 
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